Economist Podcasts Nine out of ten, doctors say: a promising coronavirus vaccine
Nov 10, 2020
Natasha Loder, Health Policy Editor, shares insights on a COVID-19 vaccine boasting 90% efficacy, discussing its potential impact and the logistical hurdles ahead. Kinley Salmon, Africa Correspondent, analyzes recent African elections, revealing strongman tactics undermining democracy and the hope for positive change in nations like Ghana. The conversation also touches on India’s evolving stance on cannabis and how cultural contradictions mirror broader societal shifts.
AI Snips
Chapters
Transcript
Episode notes
Vaccine Safety
- While the vaccine appears safe in early trials, more safety data is necessary.
- Long-term effects are still unknown due to the limited observation time.
Remaining Questions
- Key questions about the vaccine's efficacy in elderly people and its ability to prevent transmission remain.
- The long-term efficacy of the vaccine is also unknown and needs further study.
Distribution Challenges
- Vaccine distribution presents enormous logistical challenges, particularly due to the vaccine’s storage requirements.
- Ramping up production and securing deals with various governments and international organizations are crucial next steps.